BDZ-g（Cat No.:I023130）is a synthetic small molecule compound, often used in research related to the modulation of gamma-aminobutyric acid (GABA) receptors. BDZ-g acts as a positive allosteric modulator, enhancing the activity of GABA receptors, which are involved in inhibitory neurotransmission in the central nervous system. By potentiating GABA receptor function, BDZ-g has been studied for its potential neuroprotective and anxiolytic effects. It may have therapeutic applications in treating conditions such as anxiety disorders, epilepsy, and other neuropsychiatric diseases where GABAergic dysfunction plays a role in pathophysiology.